| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 9,950 | 60,824 | 43,576 | | Cost of Revenue | 2,540 | 3,481 | 3,212 | | | Gross Profit | 7,410 | 57,343 | 40,363 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 255 | 237 | 290 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,155 | 57,105 | 40,073 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (113,144) | (68,617) |
-
| | Earnings Before Interest And Taxes | 7,155 | 15,510 | 12,755 | | Interest Expense | 2,050 | 4,046 | 3,075 | | Income Before Tax | 5,105 | 11,464 | 9,680 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (108,039) | (15,558) | 36,998 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (108,039) | (15,558) | 36,998 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($108,039) | ($15,558) | $36,998 |
|
0.11% Nasdaq 0.00%
Income Statement
